Drug Type Monoclonal antibody |
Synonyms ADNC, Anti-D monoclonal antibody, Anti-RhD-antibody + [6] |
Target |
Mechanism Rh factor inhibitors(Blood group Rh(D) polypeptide inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Erythroblastosis, Fetal | Phase 3 | FR | 12 Mar 2014 | |
Anemia, Hemolytic | Phase 2 | FR | 01 Apr 2014 | |
Rh-Null, Regulator Type | Phase 2 | FR | 01 Apr 2014 | |
Rheumatic Heart Disease | Phase 2 | FR | 01 Apr 2014 |
Phase 2 | 62 | (Population PK (PKS1)) | jjrppsowul(qfdfjtnmne) = daqblsgvqq ihbcplijnu (ukwabkquet, qznmfihvyp - bathhwuvva) View more | - | 16 Aug 2019 | ||
(IM Arm Roledumab) | ytinwdnetm(hzdncddwwh) = hmfwegnddg yigazqeldf (sxhuxzuzst, nlwxlflezk - tibkwmxkxs) View more |